Gene Burleson - SunLink Health Independent Director
| SSY Stock | USD 0.86 0.11 14.67% |
Director
Mr. Gene E. Burleson is an Independent Director of the company. He is a private investor and was Chairman of PET DRx Corporation from June 2005 to July 1, 2010 and its Chief Executive Officer from October 2008 until its acquisition by VCA Antech in July 2010. Mr. Burleson was a director of HealthMont Inc. from September 2000 until its acquisition by SunLink in October 2003. Mr. Burleson served as Chairman of Mariner PostAcute Network, Inc. from January 2000 to June 2002. Mr. Burleson was Chairman of the Board of GranCare Inc. from October 1990 to November 1997 and President and Chief Executive Officer of GranCare Inc. from December 1989 to February 1997. From June 1986 to March 1989 Mr. Burleson served as President, Chief Operating Officer and Director of American Medical International Inc. . Mr. Burleson served as Managing Director of AMIs international operations from May 1981 to June 1986. Mr. Burleson was deemed qualified to serve on the board for the reasons set forth below under Director Qualifications, including his business experience set forth herein. since 2003.
| Age | 77 |
| Tenure | 21 years |
| Address | 900 Circle 75 Parkway, Atlanta, GA, United States, 30339 |
| Phone | 770 933 7000 |
| Web | https://www.sunlinkhealth.com |
Gene Burleson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Gene Burleson against SunLink Health stock is an integral part of due diligence when investing in SunLink Health. Gene Burleson insider activity provides valuable insight into whether SunLink Health is net buyers or sellers over its current business cycle. Note, SunLink Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell SunLink Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Gene Burleson over three months ago Acquisition by Gene Burleson of 3000 shares of SunLink Health at 0.71 subject to Rule 16b-3 | ||
Gene Burleson over three months ago Disposition of 3000 shares by Gene Burleson of SunLink Health at 0.71 subject to Rule 16b-3 | ||
Gene Burleson over six months ago Acquisition by Gene Burleson of 10000 shares of SunLink Health at 1.38 subject to Rule 16b-3 |
SunLink Health Management Efficiency
The company has Return on Asset of (0.0954) % which means that on every $100 spent on assets, it lost $0.0954. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1476) %, meaning that it generated no profit with money invested by stockholders. SunLink Health's management efficiency ratios could be used to measure how well SunLink Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, SunLink Health's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.01 in 2024, despite the fact that Return On Capital Employed is likely to grow to (0.04). At this time, SunLink Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 24.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.7 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Jessica Blume | Centene Corp | 66 | |
| Karen Katz | Humana Inc | 64 | |
| Robert Ditmore | Centene Corp | 86 | |
| Glenn Renwick | UnitedHealth Group Incorporated | 64 | |
| David Jones | Humana Inc | 71 | |
| Tommy Thompson | Centene Corp | 78 | |
| Valerie Rice | UnitedHealth Group Incorporated | 58 | |
| Kimberly Ross | Cigna Corp | 56 | |
| Roman Martinez | Cigna Corp | 71 | |
| David Feinberg | Humana Inc | 58 | |
| Frank Bisignano | Humana Inc | 62 | |
| Marissa Peterson | Humana Inc | 58 | |
| Eric Wiseman | Cigna Corp | 65 | |
| Mark McClellan | Cigna Corp | 57 | |
| Lori Robinson | Centene Corp | 62 | |
| William Ballard | UnitedHealth Group Incorporated | 77 | |
| William McDonald | Humana Inc | 64 | |
| Orlando Ayala | Centene Corp | 64 | |
| John Partridge | Cigna Corp | 71 | |
| Timothy Flynn | UnitedHealth Group Incorporated | 64 | |
| Donna Zarcone | Cigna Corp | 63 | |
Management Performance
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0954 |
SunLink Health Systems Leadership Team
Elected by the shareholders, the SunLink Health's board of directors comprises two types of representatives: SunLink Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SunLink. The board's role is to monitor SunLink Health's management team and ensure that shareholders' interests are well served. SunLink Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SunLink Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| C Ford, Independent Director | ||
| James Mulligan, General Emeritus | ||
| Sheila Brockman, Vice President | ||
| Mark Stockslager, Chief Financial Officer, Principal Accounting Officer | ||
| Theresa Mota, Secretary | ||
| Byron CPA, LLC ScriptsRX | ||
| Gene Burleson, Independent Director | ||
| Karen Brenner, Independent Director | ||
| Howard Turner, Independent Director | ||
| Steven Baileys, Independent Director | ||
| Christopher Mills, Independent Director | ||
| Byron Finn, President of SunLink ScriptsRx, LLC. | ||
| Robert Thornton, Executive Chairman, CEO and President and Chairman of Executive Committee | ||
| Neal Miller, Inc Technology |
SunLink Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SunLink Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0954 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.15) % | ||||
| Current Valuation | (988.73 K) | ||||
| Shares Outstanding | 7.04 M | ||||
| Shares Owned By Insiders | 26.60 % | ||||
| Shares Owned By Institutions | 13.44 % | ||||
| Number Of Shares Shorted | 17.88 K | ||||
| Price To Earning | 3.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SunLink Stock Analysis
When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.